Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-04-15 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
S | Common Stock | D | 19818 | $133.36 - $133.36 | $2,643,019 |
| 2024-04-15 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
M | Common Stock | A | 19818 | $81.05 - $81.49 | $1,609,430 |
| 2024-03-21 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 5000 | $145.06 - $145.06 | $725,320 |
| 2024-03-21 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 5000 | $103.52 - $103.52 | $517,600 |
| 2024-03-14 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
S | Common Stock | D | 75000 | $139.38 - $139.38 | $10,453,416 |
| 2024-03-14 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
M | Common Stock | A | 75000 | $79.02 - $81.05 | $6,067,627 |
| 2024-03-14 | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J
(Director) |
S | Common Stock | D | 40000 | $139.41 - $139.42 | $5,576,710 |
| 2024-03-14 | NEUROCRINE BIOSCIENCES INC | MORROW GEORGE J
(Director) |
M | Common Stock | A | 40000 | $39.79 - $39.79 | $1,591,600 |
| 2024-03-13 | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F
(Director) |
S | Common Stock | D | 23200 | $140.33 - $140.33 | $3,255,621 |
| 2024-03-13 | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F
(Director) |
M | Common Stock | A | 23200 | $42.76 - $42.76 | $992,032 |
| 2024-03-13 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 3000 | $140.14 - $140.14 | $420,419 |
| 2024-03-13 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 3000 | $106.02 - $106.02 | $318,060 |
| 2024-03-08 | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F
(Director) |
S | Common Stock | D | 1800 | $140.00 - $140.05 | $252,078 |
| 2024-03-08 | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F
(Director) |
M | Common Stock | A | 1800 | $42.76 - $42.76 | $76,968 |
| 2024-03-08 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 2000 | $140.00 - $140.03 | $280,052 |
| 2024-03-08 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 2000 | $106.02 - $106.02 | $212,040 |
| 2024-02-28 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 6817 | $134.62 - $136.00 | $922,631 |
| 2024-02-28 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
M | Common Stock | A | 6817 | $79.02 - $79.02 | $538,678 |
| 2024-02-28 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
S | Common Stock | D | 75000 | $134.69 - $134.69 | $10,101,606 |
| 2024-02-28 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
M | Common Stock | A | 75000 | $43.24 - $79.02 | $4,025,043 |
| 2024-02-27 | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V
(Director) |
S | Common Stock | D | 8000 | $135.67 - $135.67 | $1,085,388 |
| 2024-02-27 | NEUROCRINE BIOSCIENCES INC | Norwalk Leslie V
(Director) |
M | Common Stock | A | 8000 | $84.95 - $84.95 | $679,600 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
S | Common Stock | D | 1114 | $132.96 - $132.96 | $148,121 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | Onyia Jude
(Chief Scientific Officer) |
S | Common Stock | D | 1432 | $132.94 - $132.94 | $190,371 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
S | Common Stock | D | 1098 | $132.99 - $132.99 | $146,028 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES
(Chief Executive Officer) |
S | Common Stock | D | 2832 | $133.02 - $133.02 | $376,700 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | Gano Kyle
(Chief Business Development Off) |
S | Common Stock | D | 1352 | $132.89 - $132.89 | $179,673 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 716 | $133.03 - $133.03 | $95,252 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
S | Common Stock | D | 796 | $133.04 - $133.04 | $105,902 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | Boyer David W.
(Chief Corp. Affairs Officer) |
S | Common Stock | D | 1811 | $133.05 - $133.10 | $240,995 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
S | Common Stock | D | 1352 | $132.85 - $132.85 | $179,611 |
| 2024-02-13 | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES
(Chief Executive Officer) |
M | Common Stock | A | 5090 | $35.99 - $43.24 | $199,950 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | Boyer David W.
(Chief Corp. Affairs Officer) |
S | Common Stock | D | 1784 | $134.19 - $141.96 | $244,562 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
S | Common Stock | D | 2544 | $134.23 - $142.17 | $352,610 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
S | Common Stock | D | 2101 | $134.21 - $142.24 | $290,967 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
S | Common Stock | D | 1952 | $134.24 - $142.17 | $270,283 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES
(Chief Executive Officer) |
S | Common Stock | D | 5314 | $134.15 - $142.18 | $737,270 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | Gano Kyle
(Chief Business Development Off) |
S | Common Stock | D | 2580 | $134.20 - $142.20 | $359,041 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
S | Common Stock | D | 2260 | $134.19 - $142.12 | $313,418 |
| 2024-02-06 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
S | Common Stock | D | 2260 | $134.21 - $142.19 | $313,529 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
S | Common Stock | D | 1457 | $140.79 - $140.79 | $205,131 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | Onyia Jude
(Chief Scientific Officer) |
S | Common Stock | D | 126 | $141.94 - $141.94 | $17,884 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
S | Common Stock | D | 1250 | $140.65 - $140.65 | $175,809 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES
(Chief Executive Officer) |
S | Common Stock | D | 2707 | $140.69 - $140.69 | $380,844 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | Gano Kyle
(Chief Business Development Off) |
S | Common Stock | D | 1541 | $140.70 - $140.70 | $216,812 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | Delaet Ingrid
(Chief Regulatory Officer) |
S | Common Stock | D | 1045 | $139.77 - $141.94 | $146,974 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | Cooke Julie
(Chief Human Resources Officer) |
S | Common Stock | D | 1740 | $140.70 - $141.94 | $245,840 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | Boyer David W.
(Chief Corp. Affairs Officer) |
S | Common Stock | D | 2096 | $140.72 - $140.87 | $295,114 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC
(Chief Commercial Officer) |
S | Common Stock | D | 1207 | $140.78 - $140.78 | $169,926 |
| 2024-01-31 | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT
(Chief Financial Officer) |
S | Common Stock | D | 1283 | $140.72 - $140.72 | $180,538 |
| 2024-01-22 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
S | Common Stock | D | 10000 | $139.86 - $139.86 | $1,398,553 |
| 2024-01-22 | NEUROCRINE BIOSCIENCES INC | Lippoldt Darin
(Chief Legal Officer) |
M | Common Stock | A | 10000 | $79.02 - $79.02 | $790,200 |
| 2024-01-02 | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H
(Director) |
S | Common Stock | D | 11044 | $131.47 - $131.47 | $1,451,927 |
| 2024-01-02 | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H
(Director) |
M | Common Stock | A | 20000 | $12.98 - $12.98 | $259,600 |
| 2023-12-22 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
S | Common Stock | D | 10000 | $126.74 - $126.74 | $1,267,448 |
| 2023-12-12 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
S | Common Stock | D | 13925 | $120.30 - $120.31 | $1,675,239 |
| 2023-12-12 | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY
(Chief Medical Officer) |
M | Common Stock | A | 13925 | $81.05 - $81.05 | $1,128,620 |
| 2023-11-29 | NEUROCRINE BIOSCIENCES INC | Onyia Jude
(Chief Scientific Officer) |
S | Common Stock | D | 2331 | $113.57 - $113.57 | $264,732 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |